Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?

Cancer immunology research - 1 Jun 2014

Lutz Eric R, Jaffee Elizabeth M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Cancer Vaccines
Share to Epitopes, T-Lymphocyte
Share to Histocompatibility Antigens Class I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunity, Cellular

Share to Neoplasms

Share to Precision Medicine

Share to T-Lymphocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 24795140
DOI: 10.1158/2326-6066.CIR-14-0041
PMCID: PMC4343532

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?PMID 24795140Read ↗

Neoepitopes of Cancers: Looking Back, Looking Ahead.Semantic proximity Read ↗

Clinical implications of neoepitope landscapes for adult and pediatric cancers.Semantic proximity Read ↗

Neoepitopes as Difference Makers for General Cancer Vaccines?Semantic proximity Read ↗

Neoepitopes as Cancer Immunotherapy Targets: Key Challenges and OpportunitiesSemantic proximity Read ↗

An unbiased approach to defining bona fide cancer neoepitopes that elicit immune-mediated cancer rejectionSemantic proximity Read ↗

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapySemantic proximity Read ↗

Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.Semantic proximity Read ↗

Structural and physical features that distinguish tumor-controlling from inactive cancer neoepitopesSemantic proximity Read ↗

Identification of neoantigens for individualized therapeutic cancer vaccinesSemantic proximity Read ↗

The double-edged sword of cancer mutations: exploiting neoepitopes for the fight against cancer.Semantic proximity Read ↗

Tumor neoantigens: building a framework for personalized cancer immunotherapy.Semantic proximity Read ↗

Cancer immunotherapy: exploiting neoepitopes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.